Understand the source comparison
P21 Stacking: Research Context Comparison
Neurogenesis + synaptic integration P21 3–5mg/day Semax Amidate 300–600mcg/day, Dihexa 5–10mg/day P21 stimulates neural stem cell proliferation, Semax enhances BDNF/NGF, Dihexa accelerates synaptogenesis P21 BID, Semax QD morning, Dihexa QD morning Mechanistic
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Neurogenesis + synaptic integration
- P21 3–5mg/day
- Semax Amidate 300–600mcg/day, Dihexa 5–10mg/day
- P21 stimulates neural stem cell proliferation, Semax enhances BDNF/NGF, Dihexa accelerates synaptogenesis
- P21 BID, Semax QD morning, Dihexa QD morning
- Mechanistically sound. Addresses neuron formation, growth factor support, and synaptic efficiency through non-overlapping pathways
- Neuroprotection + vascular support
- BPC-157 250–500mcg/day, TB-500 2–5mg twice weekly
- P21 promotes neurogenesis, BPC-157 drives angiogenesis, TB-500 supports tissue repair and cell migration
- P21 BID with BPC-157, TB-500 biweekly
- Strong pairing. New neurons require robust blood flow; BPC and TB address the vascular and structural support P21 doesn't target
- Cognitive enhancement + metabolic optimization
- MOTS-C 5–10mg 3x/week, SS-31 5mg/day
- P21 enhances neuroplasticity, MOTS-C regulates metabolic homeostasis via AMPK, SS-31 stabilizes mitochondrial function
- P21 BID, MOTS-C TIW, SS-31 QD
- Mechanistically complementary. Addresses neural adaptation while removing metabolic and bioenergetic constraints
- Broad-spectrum neuroprotection
- Cerebrolysin 5–10mL 5 days/week
- P21 targets CNTF pathway, Cerebrolysin provides multi-pathway neurotrophic factor support
- P21 BID, Cerebrolysin QD 5 days on / 2 days off
- Classic research pairing. Cerebrolysin's broad mechanism complements P21's targeted neurogenesis without pathway redundancy